Showing results (211-220 of 372) with videos related to

Sort By:
Pageof 38
Neoplasia (New York, N.Y.)|July 13, 2012
RANK (TNFRSF11A) is epigenetically inactivated and induces apoptosis in gliomasAnna von dem Knesebeck, Jörg Felsberg, Anke Waha, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 1, 2018
Safety and efficacy of targeted alpha therapy with 213Bi-DOTA-substance P in recurrent glioblastomaLeszek Królicki, Frank Bruchertseifer, Jolanta Kunikowska, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 2, 2018
Prolonged survival in secondary glioblastoma following local injection of targeted alpha therapy with 213Bi-substance P analogueLeszek Krolicki, Frank Bruchertseifer, Jolanta Kunikowska, et al.
Clinical Chemistry and Laboratory Medicine|June 9, 2015
Assessing quality and functionality of DNA isolated from FFPE tissues through external quality assessment in tissue banksParviz Ahmad-Nejad, Angelika Duda, Antje Sucker, et al.
Neuro-Oncology|May 19, 2026
cIMPACT-NOW update 12: Refining Pathology-based Risk Stratification and Grading for IDH-mutant GliomasDaniel J Brat, Kenneth Aldape, Pim J French, et al.
Neuro-Oncology|January 30, 2016
Complete resection of contrast-enhancing tumor volume is associated with improved survival in recurrent glioblastoma-results from the DIRECTOR trialBogdana Suchorska, Michael Weller, Ghazaleh Tabatabai, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 9, 2014
Toso controls encephalitogenic immune responses by dendritic cells and regulatory T cellsDirk Brenner, Anne Brüstle, Gloria H Y Lin, et al.
Acta Neuropathologica|September 2, 2019
FOCAD loss impacts microtubule assembly, G2/M progression and patient survival in astrocytic gliomasFrank Brand, Alisa Förster, Anne Christians, et al.
Clinical Neuropathology|May 1, 2020
Quality assurance in neuropathology: Experiences from the round robin trials on IDH mutation and MGMT promoter methylation testing launched by the Quality Assurance Initiative Pathology (QuIP) in 2018 and 2019Markus J Riemenschneider, Josephine Fischer, Maja Grassow-Narlik, et al.
Cancer Research|February 4, 2010
Epigenetic downregulation of mitogen-activated protein kinase phosphatase MKP-2 relieves its growth suppressive activity in glioma cellsAnke Waha, Jörg Felsberg, Wolfgang Hartmann, et al.
Pageof 38